lobbying_activities: 3430801

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3430801	157307ba-b974-4b98-9261-062fe48b5258	Q3	BIOCOM	400552652	BIOCOM	2025	third_quarter	CPT	Advocated for the protection of Intellectual Property rights Expressed opposition to FDA and PTO activities that would undermine IP rights. Advocated against policies that would negatively impact technology transfer programs at universities Advocated in support of less restrictive merger & acquisition policies in life sciences Advocated for a reformed PTAB Advocated for Section 101 reforms that provide clearer guidelines on what constitutes patentable subject matter Advocated for granting injunctions with respect to infringing conduct once a court enters a final judgement against an infringer.	HOUSE OF REPRESENTATIVES,SENATE		75000	0	0	2025-10-13T09:47:47-04:00